BIOCYTOGEN-B Now Included in Securities Eligible for Southbound Stock Connect, Effective Immediately
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 24 2025
0mins
Source: aastocks
Stock Addition Announcement: The Shenzhen Stock Exchange has added BIOCYTOGEN-B (02315.HK) to the list of securities eligible for the Southbound Stock Connect, effective today, October 24th.
Stock Performance: Following the announcement, BIOCYTOGEN-B experienced a significant increase in its stock price, rising by 6.320, which represents a 22.021% gain.
Analyst Views on 02315
Wall Street analysts forecast 02315 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02315 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 35.820
Low
Averages
High
Current: 35.820
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
